Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Given that weight control and a low risk of hypoglycaemia are key considerations for this patient, the addition of a GLP-1RA may be the most appropriate choice
Semaglutide products, such as Ozempic and Wegovy, have been in short supply in Australia due to demand with the TGA issuing advice last year not to initiate new patients on the drug unless there is a compelling clinical reason to do so
Disclaimer: This information should be considered exploratory unless supported by definitive clinical evidence
Pancreatitis, gallbladder disease, and rare thyroid tumors are listed in boxed warnings
US$ 22.37
US$ 25.15
US$ 22.02
